Literature DB >> 31851722

Awareness, willingness to use, and history of HIV PrEP use among gay, bisexual, and other men who have sex with men in Nigeria.

Adedotun Ogunbajo1,2, Stella Iwuagwu3, Rashidi Williams4, Katie Biello1,2,5,6, Matthew J Mimiaga1,2,5,6,7.   

Abstract

BACKGROUND: Nigerian gay, bisexual, and other men who have sex with men (GBMSM) are disproportionately affected by HIV, with an estimated prevalence of between 11-35%. Pre-exposure prophylaxis (PrEP) has the potential to significantly decrease incident HIV infections among Nigerian GBMSM. Understanding the relationship between socio-demographic, sexual risk behavior, and psychosocial factors with PrEP awareness, willingness to use, and history of use among this group is pivotal to maximizing PrEP uptake.
METHODS: Between March and June 2019, 419 participants completed an interviewer-administered survey assessing PrEP awareness, willingness to use, and history of use; socio-demographics; sexual risk behavior; and psychosocial factors. Bivariate and multivariable logistic regression were used to examine factors associated with PrEP awareness, willingness to use, and history of use.
RESULTS: 53.6% were aware of PrEP; 80.1% were willing to use PrEP; and 29.7% had previously used PrEP. In multivariable analysis, factors associated with an increased odds of PrEP awareness include residing in Abuja [adjusted odds ratio (aOR) 5.02; 95% confidence interval (CI): 2.13 to 11.83] and Lagos (aOR 12.30; 95% CI: 4.92 to 30.67) vs. residing in Plateau, living with HIV (aOR 2.56; 95% CI: 1.54 to 4.72), using location-based apps for seeking sexual partners (aOR 4.06; 95% CI: 2.28 to 7.24), having health insurance (aOR 2.31; 95% CI: 1.08 to 4.40), history of suicidal thoughts (aOR 2.05; 95% CI: 1.02 to 4.10), and history of PrEP use (aOR 45.5; 95% CI: 5.60 to 370.04). Decreasing clinically significant depressive symptoms was associated with lower willingness to use PrEP (aOR 0.96; 95% CI: 0.92 to 0.99). Lastly, factors associated with increased odds of having a history of PrEP use were those reporting 6 or more insertive anal sex acts in the last 30 days compared to those with none (aOR 5.76; 95% CI: 1.58 to 20.98) and being aware of PrEP (aOR 29.6; 95% CI: 3.78 to 231.84). DISCUSSION: Nearly half of the Nigerian GBMSM in this study had no prior awareness of PrEP, but after being informed about its potential benefits, the majority were willing to use it. However, PrEP uptake among Nigerian GBMSM remains low. Findings suggest that educational messages are necessary to ensure appropriate PrEP scale-up, especially tailored towards Nigerian GBMSM.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31851722      PMCID: PMC6919589          DOI: 10.1371/journal.pone.0226384

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Nigeria has the fourth largest human immunodeficiency virus (HIV) epidemic in the world, with a prevalence of 1.4% among the general adult population and an estimated 1.9 million people living with HIV [1]. Nigerian gay, bisexual and other men who have sex with men (GBMSM) bear a disproportionately higher burden of HIV, with an estimated prevalence of 11–35% [2]. Oral pre-exposure prophylaxis (PrEP) is a biomedical prevention approach that significantly reduces HIV acquisition when taken daily [3-5]. Given its’ efficacy, PrEP has the potential to significantly decrease new HIV infections among Nigeria GBMSM. In 2013, a consultation of community leaders, implementers, and academics from17 African countries gathered to assess HIV prevention priorities for GBMSM and identified oral PrEP as a major biomedical prevention strategy [6]. Currently, PrEP is not widely available in Nigeria, however there are two ongoing implementation and demonstration projects with an estimated 400–600 individuals currently taking PrEP [7]. Gaining an in-depth understanding of awareness of and acceptability of PrEP among Nigerian GBMSM is crucial for preparing for PrEP uptake, once it becomes more widely available. To date, only a few studies have investigated PrEP awareness, acceptability, and current use among African GBMSM. A recently published study of 459 HIV-negative Kenyan GBMSM found that 64.3% had awareness of PrEP and 44.9% were willing to use PrEP in the future [8]. Another study of 137 GBMSM in Ghana found low awareness but high acceptability of PrEP [9]. These studies provide preliminary evidence of PrEP being acceptable by African GBMSM. To date, there are no known published studies that have explored the relationship between socio-demographic, sexual risk behavior, and psychosocial factors with PrEP awareness, willingness to use PrEP, and history of PrEP use for HIV prevention among Nigerian GBMSM. The goal of the current study is to examine these relationships among a community-recruited sample of GBMSM in four diverse regions of Nigeria. Understanding these relationships will be helpful for designing successful intervention programs to increase PrEP uptake among this marginalized group.

Methods

Participants and procedures

Between March and June 2019, 413 GBMSM enrolled in the study and completed a quantitative assessment. Inclusion criteria were: 1) 18 years of age or older; 2) currently residing in one of four Nigerian states (Abuja, Lagos, Delta or Plateau); 3) cis-gender male; and 4) having sex with another male. Participants were recruited through community-based organizations (CBOs) in each of the four states and via snowball sampling. Outreach workers and peer educators at the respective CBOs shared information about the study with the target population during programming events (e.g., HIV testing and counseling, health education, advocacy events, etc.) and provided study contact information to individuals who were interested. Eligible participants were then asked to provide study information to their peer networks. Study activities took place in private offices within our partner CBOs. The study was approved by the institutional review boards at Brown University and the Nigerian Institute of Medical Research. Informed verbal consent was obtained from each participant prior to enrolling them in study. Each participant completed an interviewer administered behavioral survey. Participants were compensated 4,000 Naira (10 US dollars) for their participation.

Measures

Demographics

Participants were asked their age, relationship status, education level and sexual orientation.

Social marginalization

Participants were asked their monthly income, employment status, financial hardship, and any history of incarceration.

Sexual health

Participants were asked their sexual position, HIV status, and any history of sexually transmitted infections (STIs), any STIs in the last year, number of receptive and insertive anal sex partners in the last 30 days, condom use at last anal sex, and any usage of geosocial networking apps.

Healthcare access

Participants were asked whether or not they had a current primary care provider (yes/no), health insurance (yes/no), and whether they had been unable to access healthcare in the last year due to costs (yes/no).

Mental health

Participants were asked about depressive symptoms using the Center for Epidemiologic Studies Depression Scale (CES-D) [10], a 20-item scale used to screen for clinically significant depressive symptoms. The items were scored on a 4-point scale from 0–3, with a higher score indicating higher levels of depressive symptoms. Previous suicide thoughts were assessed by asking participants: “Have you ever thought about ending your life or committing suicide?” (yes/no). Internalized homophobia was assessed using a three-item scale scored on 5-point Likert scale [11], with a higher score indicating higher levels of internalized homophobia.

Substance use

Participants were asked about their alcohol and drug use. Problematic alcohol use was assessed with the AUDIT-C [12], a 3-item screening for heavy drinking or alcohol dependence. The AUDIT-C is scored on a scale of 0–12; a score of 4 or greater indicated hazardous drinking. Participants were asked about having ever used recreational drugs, including (marijuana, tramadol, rophynol (flunitrazepam), codeine, poppers (alkyl nitrites), and cocaine) (yes/no).

PrEP awareness, willingness to use PrEP and history of using PrEP

To assess PrEP awareness, participants were asked: “Have you heard of pre-exposure prophylaxis (PrEP) for HIV prevention?” (yes/no). To assess willingness to use PrEP, participants were provided some brief information about PrEP (i.e., PrEP is one pill taken once daily by HIV-negative people to reduce their risk of HIV infection) and then asked: “Would you be willing to take an oral pill every day to prevent getting HIV infection?” (willing/not willing/not sure, dichotomized into willing/not willing or not sure). We excluded participants who self-reported currently living with HIV as there are not eligible to take PrEP. To assess history of PrEP use, participants were asked: “Have you ever taken PrEP to prevent HIV?” (yes/no). We excluded participants who self-reported living with HIV and those currently residing in Delta or Plateau state, where PrEP is currently unavailable.

Data analysis

We assessed the distribution (percentages and means) of all variables by PrEP awareness, willingness to use, and history of use. Chi-square global tests of independence were used to assess independent association between variables. Bivariate logistic regression was conducted to assess the association between socio-demographic, sexual risk behavior, and psychosocial factors and the three PrEP-related outcomes (PrEP awareness, willingness to use PrEP, and history of PrEP use). It was determined that a sample size of 400 GBMSM (100 recruited in each of the four states) would provide 80% power to detect a 30% or greater difference in PrEP awareness between the four States sampled at a two sided .05 significance level. Variables significant at the p<0.05 level in the bivariate models were retained in each of the three multivariable models assessing these outcomes. Data were analyzed using SAS version 9.4 (Cary, NC).

Results

As seen in Table 1, Participants ranged in age from 18 to 60 years (mean = 29.2, SD = 5.8), with 59.4% identifying as bisexual, and 62.3% were single. More than a third (37.7%) of the sample was living with HIV and 32.1% had an STI diagnosis in the last year. Almost half (48.8%) had a primary care provider but only 15.6% had health insurance. The depression scores ranged from 0 to 60 with a mean score of 10.0 (SD = 11.5); 23.7% of participants had a score of 16 or higher, indicating moderate to severe depression. 18.9% of participants were indicated for hazardous drinking and history of drug use were prevalent: marijuana (42.2%), tramadol (15.2%), rophynol (15.1%), codeine (24.1%), poppers (8.6%), cocaine (7.1%). More than half the sample (53.6%) were aware of PrEP, 80.1% were willing to use PrEP, and 29.7% had a history of PrEP use.
Table 1

Socio-demographic, sexual risk behavior, and psychosocial factors associated with PrEP awareness, willingness to use PrEP, and history of PrEP use among Nigerian GBMSM from March-June 2019 (N = 413).

Total Sample (N = 413)Awareness of PrEP (n = 401)PWillingness to Use PrEP (n = 251)PPrEP Use (n = 138)P
Aware of PrEP (n = 215, 53.6%)Unaware of PrEP (n = 186, 46.4%)Willing (n = 201, 80.1%)Not Willing/Not Sure (n = 50, 19.9%)History of PrEP Use (n = 41, 29.7%)No history of PrEP Use (n = 97, 70.3%)
Site
Abuja104 (26.1)74 (71.2)30 (28.8)<0.000139 (73.6))14 (26.4)0.4918 (33.3)36 (66.7)0.54
Delta100 (25.1)31 (31.0)69 (69.0)56 (84.9)10 (15.1)--
Lagos109 (27.4)91 (83.5)18 (16.5)64 (79.0)17 (21.0)23 (28.4)58 (71.6)
Plateau85 (21.4)19 (22.4)66 (77.7)39 (81.3)9 (18.7)--
Socio-Demographics
Age
Mean (SD)29.2 (5.80)29.9 (5.16)29,7 (7.09)0.7228.9 (5.80)30.8 (5.74)0.0428.0 (5.60)29.6 (5.74)0.13
Relationship Status
Single250 (62.3)146 (58.4)104 (41.6)0.01130 (83.3)26 (16.7)0.0930 (32.9)61 (67.0)0.24
Not Single151 (37.7)69 (45.7)82 (54.3)71 (74.7)24 (25.3)11 (23.4)36 (76.6)
Education
SSS or lower182 (45.4)78 (42.9)104 (57.1)<0.000186 (81.1)20 (18.9)0.4616 (27.1)43 (72.9)0.67
Some Uni or Vocation Sch86 (21.5)40 (46.5)46 (53.546 (83.6)9 (16.4)6 (27.3)16 (72.7)
College degree or higher109 (27.2)83 (76.2)26 (23.9)57 (79.2)15 (20.8)14 (30.4)32 (69.6)
Other24 (6.0)14 (56.3)10 (41.7)12 (66.7)6 (33.3)5 (45.5)6 (54.5)
Sexual Orientation
Gay/Homosexual162 (40.6)92 (56.8)70 (43.2)0.2668 (76.4)21 (23.6)0.3017 (31.5)37 (68.5)0.56
Bisexual237 (59.4)121 (51.1)116 (48.9)131 (81.9)29 (18.1)22 (26.8)60 (73.2)
Monthly Income (in Naira)
0–10000103 (26.0)50 (48.5)53 (515)0.00847 (85.5)8 (14.5)0.207 (21.9)25 (78.1)0.35
10,000–30,000106 (26.7)46 (43.4)60 (56.6)62 (84.9)11 (15.1)12 (35.3)22 (64.7)
30,000–50,00079 (19.9)44 (55.7)35 (44.3)41 (75.9)13 (24.1)11 (40.7)16 (59.3)
50,000–100,00056 (14.1)35 (62.5)21 (37.5)24 (80.0)6 (20.0)5 (29.4)12 (70.6)
100,000+52 (13.1)37 (71.2)15 (28.8)23(67.7)11 (32.3)5 (19.2)21 (80.8)
Employment Status
Employed323 (80.5)169 (52.3)154 (47.7)0.29159 (79.5)41 (20.5)0.6531 (30.4)71 (69.6)0.77
Unemployed78 (19.5)46 (59.0)32 (41.0)42 (82.4)9 (17.6)10 (27.8)26 (72.2)
Financial Hardship
Yes241 (60.7)128 (53.1)113 (46.9)0.79119 (82.1)26 (17.9)0.3926 (33.3)52 (66.7)0.22
No156 (39.3)85 (54.5)71 (45.5)80 (77.7)23 (22.3)14 (23.7)45 (76.3)
History of Incarceration
Yes88 (22.2)46 (52.3)42 (47.7)0.7734 (87.2)5 (12.8)0.212 (11.8)15 (88.2)0.09
No309 (77.8)167 (54.0)142 (46.0)164 (78.5)45 (21.5)38 (31.9)81 (68.1)
Sexual Health
Sexual Position
Bottom/Versatile Bottom108 (27.4)60 (55.6)48 (44.4)0.8250 (83.3)10 (16.7)0.619 (24.3)28 (75.7)0.37
Versatile118 (29.9)64 (54.2)54 (45.8)57 (81.4)13 (18.6)11 (40.7)16 (59.3)
Versatile Top/Top168 (42.6)87 (51.8)81 (48.2)89 (77.4)26 (22.6)21 (30.0)49 (70.0)
Self-Reported HIV Status
Positive/Unknown151 (37.7)91 (60.3)60 (39.7)0.04N/AN/AN/AN/AN/AN/A
Negative250 (62.3)124 (49.6)126 (50.4)N/AN/AN/AN/AN/AN/A
Any History of STIs
Yes176 (44.0)103 (58.5)73 (41.5)0.09081 (80.2)20 (19.8)0.9516 (37.21)27 (62.8)0.21
No224 (56.0)112 (50.0)112 (50.0)119 (79.9)30 (20.1)25 (26.6)69 (73.4)
STIs in last year
Yes127 (32.1)70 (55.1)57 (44.9)0.6256 (78.9)15 (21.1)0.8113 (41.9)18 (58.1)0.08
No269 (67.9)141 (52.4)128 (47.6)142 (80.2)35 (19.8)27 (25.7)78 (74.3)
# of Receptive Anal sex acts in the last 30 days
0179 (44.8)87 (48.6)92 (51.4)0.0596 (78.7)26 (21.3)0.9516 (23.5)52 (76.5)0.31
156 (14.0)33 (58.9)23 (41.1)28 (80.0)7 (20.0)6 (37.5)10 (62.5)
2–382 (20.5)42 (51.2)40 (48.8)46 (83.6)9 (16.4)12 (41.4)17 (58.6)
4–552 (13.0)28 (53.9)24 (46.1)21 (77.8)6 (22.2)3 (18.8)13 (81.2)
6+31 (7.8)24 (77.4)7 (22.6)9 (81.8)2 (18.2)3 (37.5)5 (62.5)
# of Insertive Anal sex acts in the last 30 days
0134 (33.7)68 (50.8)66 (49.2)0.6966 (77.7)19 (22.3)0.878 (19.1)34 (80.9)0.05
150 (12.6)26 (52.0)24 (48.0)26 (81.3)6 (18.7))4 (20.0)16 (80.0)
2–397 (24.4)49 (50.5)48 (49.5)52 (83.9)10 (16.1)11 (30.6)25 (69.4)
4–555 (13.8)33 (60.0)22 (40.0)29 (80.6)7 (19.4)6 (33.3)12 (66.7)
6+62 (15.6)36 (58.1)26 (41.9)25 (75.8)8 (24.2)11 (55.0)9 (45.0)
Condom Use last anal sex
Yes310 (78.3)181 (58.4)129 (41.6)0.0005159 (78.7)43 (21.3)0.3537 (30.8)83 (69.2)0.46
No86 (21.7)32 (37.2)54 (62.8)39 (84.8)7 (15.2)4 (22.2)14 (77.8)
Geosocial App Usage
Yes214 (53.4)148 (69.2)66 (30.8)<0.000199 (80.5)24 (19.5)0.8722 (29.3)53 (70.7)0.92
No187 (46.6)67 (35.8)120 (64.2)102 (79.7)26 (20.3)19 (30.2)44 (89.8)
Healthcare Access
Primary care Provider
Yes196 (48.8)112 (57.1)84 (42.9)0.1796 (81.4)22 (18.6)0.6321 (31.3)46 (68.7)0.68
No205 (51.1)103 (50.2)102 (49.8)105 (78.9)28 (21.1)20 (28.2)51 (71.8)
Health Insurance
Yes62 (15.6)43 (69.3)19 (30.7)0.00732 (74.4)167 (81.1)11 (25.6)0.328 (29.6)19 (70.4)0.98
No335 (84.4)170 (50.8)165 (49.2)39 (18.9)32 (29.4)77 (70.6)
Unable to assess medical care due to cost in last year
Yes173 (43.1)83 (48.0)90 (52.0)0.0581 (77.9)23 (22.1)0.5711 (23.9)35 (76.1)0.29
No228 (56.9)132 (57.9)96 (42.1)120 (81.6)27 (18.4)30 (32.6)62 (67.4)
Mental Health
Depressive Symptoms (CESD-20)10.0 (11.5)12.1 (13.0)10.2 (11.0)0.1111.0 (12.0)6.9 (7.9)0.0210.9 (11.5)10.2 (11.6)0.75
Suicide Ideation
Yes86 (21.5)59 (68.6)27 (31.4)0.00241 (85.4)7 (14.6)0.336 (22.2)21 (77.8)0.33
No314 (78.5)155 (49.4)159 (50.6)160 (79.2)42 (20.8)35 (31.8)75 (68.2)
Internalized Homophobia7.1 (3.4)7.26 (3.4)8.66 (3.6)<0.00017.84 (3.5)7.88 (3.31)0.947.3 (3.3)7.3 (3.2)0.99
Substance Use
Hazardous Drinking (AUDIT-C)
Yes78 (18.9)48 (63.2)28 (36.8)0.0639 (73.6)14 (26.4)0.1811 (31.4)24 (68.6)0.80
No335 (81.1)167 (51.4)158 (48.6)162 (81.8)36 (18.2)30 (29.1)73 (70.9)
Lifetime Marijuana Use
Yes168 (42.2)98 (58.3)70 (41.7)0.1083 (76.2)26 (23.8)0.1520 (29.4)48 (70.6)0.89
No230 (57.8)115 (50.0)115 (50.0)116 (83.5)23 (16.5)19 (28.4)48 (71.6)
Lifetime Tramadol Use
Yes59 (15.2)35 (59.3)24 (40.7)0.3528 (80.0)7 (20.0)0.959 (45.0)11 (55.0)0.09
No330 (84.8)174 (52.7)156 (47.3)165 (80.5)40 (19.5)28 (26.2)79 (73.8)
Lifetime Rohypnol Use
Yes59 (15.1)25 (42.4)34 (57.6)0.0731 (81.6)7 (18.4)0.828 (38.1)13 (61.9)0.25
No333 (84.9)184 (55.3)149 (44.7)164 (80.0)41 (20.0)28 (25.7)81 (74.3)
Lifetime Codeine Use
Yes95 (24.1)45 (47.4)50 (52.6)0.1743 (76.8)13 (23.2)0.3813 (38.2)21 (61.8)0.12
No299 (75.9)166 (55.5)133 (44.5)155 (82.0)34 (18.0)24 (24.2)75 (75.8)
Lifetime Poppers Use
Yes34 (8.6)28 (82.4)6 (17.6)0.000414 (58.3)10 (41.7)0.0053 (15.0)17 (85.0)0.15
No369 (91.4)183 (50.8)177 (49.2)184 (82.5)39 (17.5)35 (30.7)79 (69.3)
Lifetime Cocaine Use
Yes28 (7.1)21 (75.0)7 (25.0)0.0213 (61.9)8 (38.1)0.036 (37.5)10 (62.5)0.39
No364 (92.9)189 (51.9)175 (48.1)185 (81.9)41 (18.1)32 (27.1)86 (72.9)
PrEP Indicators
Awareness of PrEP
Aware of PrEP215 (53.6)N/AN/AN/A94 (47.2)105 (52.8)0.1739 (40.6)57 (59.4)<0.0001
Unaware of PrEP186 (46.4)N/AN/A29 (58.0)21 (42.0)1 (2.5)39 (97.5)
Willingness to use PrEP
Willing201 (80.1)94 (47.2)105 (52.8)0.17N/AN/AN/A34 (32.1)72 (67.9)0.17
Not Willing/Not Sure50 (19.9)29 (58.0)21 (42.0)N/AN/A6 (19.4)25 (80.6)
PrEP Use
History of PrEP Use41 (29.7)39 (97.5)1 (2.5)<0.000134 (85.0)6 (15.0)0.17N/AN/AN/A
No History of PrEP Use97 (70.3)57 (59.4)39 (40.6)72 (74.2)25 (25.8)N/AN/A

PrEP awareness

In multivariable analysis (Table 2), factors associated with an increased odds of PrEP awareness include residing in Abuja [adjusted odds ratio (aOR) 5.02; 95% confidence interval (CI): 2.13 to 11.83] and Lagos (aOR 12.30; 95% CI: 4.92 to 30.67) vs. residing in Plateau, living with HIV (aOR 2.56; 95% CI: 1.54 to 4.72), using location-based apps for seeking sexual partners (aOR 4.06; 95% CI: 2.28 to 7.24), having health insurance (aOR 2.31; 95% CI: 1.08 to 4.40), history of suicidal thoughts (aOR 2.05; 95% CI: 1.02 to 4.10), and history of PrEP use (aOR 45.5; 95% CI: 5.60 to 370.04).
Table 2

Unadjusted and adjusted associations with PrEP awareness, willingness to use PrEP, and history of PrEP use among Nigerian GBMSM from March-June 2019.

Awareness of PrEP (n = 401)Willingness to Use PrEP (n = 251)PrEP Use (n = 138)
Unadjusted OR (95% CI)Adjusted OR (95% CI)Unadjusted OR (95% CI)Adjusted OR (95% CI)Unadjusted OR (95% CI)Adjusted OR (95% CI)
Site
Abuja8.57 (4.41–16.64) §5.02 (2.13–11.83)*0.64 (0.25–1.66)1.26 (0.60–2.65)
Delta1.56 (0.80–3.03) §1.16 (0.52–2.62)1.29 (0.48–3.47)N/A
Lagos17.56 (8.56–36.01) §12.3 (4.92–30.67) §0.87 (0.35–2.14)Ref
PlateauRefRefRefN/A
Socio-Demographics
AgeMean (SD)1.01 (0.97–1.04)0.95 (0.89–0.99)*1.04 (0.99–1.10)0.95 (0.89–1.02)
Relationship Status
Single1.67 (1.11–2.51)*1.13 (0.64–2.01)1.69 (0.90–3.16)1.61 (0.72–3.60)
Not SingleRefRefRefRef
Education
SSS or lowerRefRefRef
Some Uni or Vocation Sch1.16 (0.69–1.94)1.19 (0.50–2.82)1.01(0.34–3.03)
College degree or higher4.26 (2.51–7.23)0.88 (0.42–1.87)1.18 (0.50–2.75)
Other1.87 (0.79–4.42)0.47 (0.16–1.39)2.24 (0.60–8.37)
Sexual Orientation
Gay/HomosexualRefRefRef
Bisexual1.26 (0.84–1.88)0.72 (0.38–1.35)1.25 (0.59–2.66)
Monthly Income (in Naira)
0–10000RefRefRef
10,000–30,0000.81 (0.47–1.40)0.96 (0.36–2.57)1.95 (0.65–5.82)
30,000–50,0001.33 (0.74–2.40)0.54 (0.20–1.42)2.46 (0.79–7.65)
50,000–100,0001.77 (0.91–3.44)0.68 (0.21–2.19)1.49 (0.39–5.67)
100,000+2.62 (1.28–5.34)*0.36 (0.13–1.01)0.85 (0.24–3.08)
Employment Status
Employed0.76 (0.46–1.26)0.83 (0.37–1.85)1.14 (0.49–2.64)
UnemployedRefRefRef
Financial Hardship
Yes0.95 (0.63–1.42)1.32 (0.70–2.47)1.61 (0.75–3.45)
NoRefRefRef
History of Incarceration
Yes0.93 (0.58–1.50)1.87 (0.69–5.05)0.28 (0.06–1.31)
NoRefRefRef
Sexual Health
Sexual Position
Bottom/Versatile Bottom1.16 (0.72–1.89)1.46 (0.65–3.28)0.75 (0.30–1.86)
Versatile1.10 (0.69–1.77)1.28 (0.61–2.70)1.60 (0.64–4.04)
Versatile Top/TopRefRefRef
Self-Reported HIV Status
Positive/Unknown1.54 (1.02–2.32)*2.56 (1.54–4.72) §N/AN/A
NegativeRefRefN/AN/A
Any History of STIs
Yes1.41 (0.95–2.10)1.02 (0.54–1.92)1.64 (0.76–3.53)
NoRefRefRef
STIs in last year
Yes1.12 (0.73–1.70)0.92 (0.47–1.82)2.09 (0.90–4.82)
NoRefRefRef
# of Receptive Anal sex acts in the last 30 days
0RefRefRefRef
11.52 (0.83–2.79)1.61 (0.67–3.84)1.08 (0.43–2.76)1.95 (0.61–6.20)
2–31.11 (0.66–1.87)0.93 (0.43–1.99)1.38 (0.60–3.19)2.29 (0.91–5.80)
4–51.23 (0.66–2.29)0.63 (0.27–1.50)0.95 (0.35–2.59)0.75 (0.19–2.97)
6+3.63 (1.49–8.84)*1.90 (0.56–6.45)1.22 (0.25–5.99)1.95 (0.42–9.07)
# of Insertive Anal sex acts in the last 30 days
0RefRefRefRef
11.05 (0.55–2.01)1.25 (0.45–3.47)1.06 (0.28–4.06)1.35 (0.32–5.66)
2–30.99 (0.59–1.67)1.50 (0.64–3.49)1.87 (0.66–5.33)2.58 (0.80–8.30)
4–51.46 (0.77–2.75)1.19 (0.45–3.15)2.13 (0.61–7.39)1.67 (0.46–6.08)
6+1.34 (0.73–2.47)0.90 (0.35–2.32)5.19 (1.61–16.74)*5.76 (1.58–20.98)*
Condom Use last anal sex
Yes2.37 (1.45–3.87)§1.84 (0.90–3.76)0.66 (0.28–1.59)1.56 (0.48–5.06)
NoRefRefRefRef
Geosocial App Usage
Yes4.02 (2.65–6.09) §4.06 (2.28–7.24) §1.05 (0.57–1.95)0.96 (0.46–2.00)
NoRefRefRefRef
Healthcare Access
Primary care Provider
Yes1.32 (0.89–1.96)1.16 (0.62–2.17)1.16 (0.56–2.42)
NoRefRefRef
Health Insurance
Yes2.20 (1.23–3.93) §2.31 (1.08–4.40) *0.68 (0.32–1.47)1.01 (0.40–2.55)
NoRefRefRefRef
Unable to assess medical care due to cost in last year
Yes0.67 (0.45–0.99)*1.17 (0.65–2.10)0.79 (0.43–1.48)0.65 (0.29–1.45)
NoRefRefRefRef
Mental Health
Depressive Symptoms (CESD-20)1.01 (0.99–1.03)1.04 (1.01–1.08)*0.96 (0.92–0.99)*1.01 (0.97–1.04)
Suicide Ideation
Yes2.24 (1.35–3.72) §2.05 (1.02–4.10)*1.54 (0.64–3.67)0.61 (0.23–1.65)
NoRefRefRefRef
Internalized Homophobia0.89 (0.84–0.95) §0.96 (0.88–1.04)0.99 (0.91–1.09)1.00 (0.89–1.12)
Substance Use
Hazardous Drinking (AUDIT-C)
Yes1.62 (0.97–2.71)0.62 (0.31–1.26)1.12 (0.49–2.56)
NoRefRefRef
Lifetime Marijuana Use
Yes1.40 (0.94–2.09)0.63 (0.34–1.19)1.05 (0.50–2.22)
NoRefRefRef
Lifetime Tramadol Use
Yes1.31 (0.75–2.30)0.97 (0.40–2.38)2.31 (0.87–6.16)
NoRefRefRef
Lifetime Rohypnol Use
Yes0.60 (0.34–1.04)1.11 (0.46–2.69)1.78 (0.67–4.74)
NoRefRefRef
Lifetime Codeine Use
Yes0.72 (0.45–1.15)0.73 (0.35–1.50)1.94 (0.84–4.44)
NoRefRefRef
Lifetime Poppers Use
Yes4.51 (1.83–11.16) §3.48 (0.83–14.62)0.30 (0.12–0.72) §2.65 (0.84–8.36)0.40 (0.11–1.45)
NoRefRefRefRefRef
Lifetime Cocaine Use
Yes2.78 (1.15–6.70) §0.88 (0.22–3.56)0.36 (0.14–0.93)*1.77 (0.51–6.21)1.61 (0.54–4.80)
NoRefRefRefRefRef
PrEP Indicators
Awareness of PrEP
Aware of PrEPN/A0.65 (0.35–1.21)57.10 (7.80–417.97) §29.62 (3.78–231.84) §
Unaware of PrEPN/ARefRefRef
Willingness to use PrEP
Willing0.65 (0.35–1.21)N/A1.97 (0.74–5.24)
Not Willing/Not SureRefN/ARef
PrEP Use
History of PrEP Use26.68 (3.52–202.40) §45.53 (5.60–370.04) §1.97 (0.74–5.24)N/A
No History of PrEP UseRefRefRefN/A

§ P<0.01

*P<0.05

§ P<0.01 *P<0.05

Willingness to use PrEP

In multivariable analysis (Table 2), decreasing clinically significant depressive symptoms was associated with lower willingness to use PrEP (aOR 0.96; 95% CI: 0.92 to 0.99).

History of PrEP use

In the multivariable model (Table 2), factors associated with increased odds of having a history of PrEP use were those reporting 6 or more insertive anal sex acts in the last 30 days compared to those with none (aOR 5.76; 95% CI: 1.58 to 20.98) and being aware of PrEP (aOR 29.6; 95% CI: 3.78 to 231.84).

Discussion

This is the first quantitative study that we are aware of to explore PrEP awareness, willingness to use PrEP, and history of PrEP use among GBMSM in Nigeria and West Africa. Nearly half (46.4%) of the Nigerian GBMSM in this study had no prior awareness of PrEP, but after being informed about its potential benefits, the majority (80.1%) were willing to use it. Furthermore, PrEP uptake among Nigerian GBMSM remains low (29.7%). Our findings align with a recent review article that found relatively low PrEP awareness (16.9–44.3%) but higher willingness to use PrEP (53.3–74.8%) among GBMSM in low and middle income countries [13]. We found that residing Lagos and Abuja was significantly associated with PrEP awareness compared to residing in Plateau. This finding is likely explained by the recent availability of PrEP among GBMSM in these two states. Additionally, we found that people living with HIV had higher PrEP awareness compared to those who reported being HIV uninfected. Since recruitment occurred through CBOs, some of which provide HIV testing and counseling, and antiretroviral therapy, it is possible that people living with HIV may have been counselled on the efficacy of PrEP to decrease HIV transmission among serodiscordant sexual partnerships [14]. We found that individuals who had used location-based apps for seeking sexual partners had increased odds of being PrEP aware, compared to those who reported non-use. This finding support recommendation for using geosocial networking apps (e.g., Grindr, Badoo, etc) as potentially effective medium for dissemination of PrEP messaging as rollout expands in Nigeria, especially given thar more than half of the sample (53.4%) reported using these apps and these apps have been previously associated with greater number of sexual partners, condomless anal sex, and increased incidence of HIV and other sexually transmitted infections [15, 16]. This is especially relevant in Nigeria where homosexuality is criminalized and limited safe spaces exist for GBMSM, with many resorting to these apps to meet other GBMSM for a friendship, relationship, and/or sex. GBMSM with clinically significant depressive symptoms had a decreased odds of willingness to use PrEP. This finding highlights how mental health issues might affect interest in PrEP uptake, which is particularly important as psychosocial health problems has been associated with increased risk for HIV infection among GBMSM [17-19]. A recently published study found that experiencing 4 or more psychosocial health problems (i.e. depressive symptoms, post-traumatic stress disorder, alcohol dependence, tobacco use, and hard-drug use)–compared to experience none or one psychosocial health problem–was significantly associated with increasing number of male sexual partners among Nigerian GBMSM [20]. Previous research has highlighted the need to screen for mental health problems among GBMSM PrEP users, as it may lead to suboptimal PrEP adherence [21] and overall health [22]. We found that having 6 or more insertive anal sex partners in the last 30 days and being aware of PrEP were significantly associated with history of PrEP use. This finding may provide evidence that the current ongoing demonstration trial of PrEP in Nigeria is capturing those who are at most risk and PrEP awareness translating to PrEP uptake. This finding highlights the need for a PrEP awareness campaign, on various platforms, that provides easily understood, evidence-based information about PrEP. This campaign will help increase health literacy both around PrEP specifically and more generally on various other topics related to sexual health Information about effectiveness, costs, and common side effects should be provided. The campaign should include testimonials trusted GBMSM community members, to add credibility and relatability of the health campaign. Also, key stakeholders such as GBMSM community opinion leaders, CBOs, and geosocial networking apps are major channels for dissemination of information about PrEP to Nigerian GBMSM. Intentional engagement of these groups, at every step, is pivotal to increasing PrEP knowledge among Nigerian GBMSM, which would facilitate PrEP uptake and adherence. These findings should be examined in the context of some study limitations The cross-sectional design limits our ability to draw causal inferences from our findings. In addition, participants were mainly recruited through GBMSM community-based organizations and GBMSM social networks, thus findings may not be generalizable to GBMSM who do not seek services at these CBOS or are outside of these social networks. In addition, many of the measures relied on participant recall/self-report (e.g., HIV status); future studies should use more objective measurements when possible. Despite these limitations, this is among the first known quantitative analyses of PrEP awareness/acceptability among Nigerian GBMSM. Additionally, this is the first study to sample GBMSM from four distinct regions of the country, which provided for a diverse sample of varied experiences.

Conclusions

Taken together, we found that nearly half of the Nigerian GBMSM in this study had no prior awareness of PrEP, but after being informed about its potential benefits, the majority were willing to use it. Furthermore, PrEP uptake among Nigerian GBMSM remains low. Findings suggest that educational messages are necessary to ensure appropriate PrEP scale-up, especially tailored towards Nigerian GBMSM.
  16 in total

1.  Awareness and Acceptability of pre-exposure prophylaxis (PrEP) among gay, bisexual and other men who have sex with men (GBMSM) in Kenya.

Authors:  Adedotun Ogunbajo; Augustine Kang; Sylvia Shangani; Ryan M Wade; Daniel P Onyango; Wilson W Odero; Gary W Harper
Journal:  AIDS Care       Date:  2019-04-30

2.  A syndemic of psychosocial health problems is associated with increased HIV sexual risk among Nigerian gay, bisexual, and other men who have sex with men (GBMSM).

Authors:  Adedotun Ogunbajo; Temitope Oke; Harry Jin; William Rashidi; Stella Iwuagwu; Gary W Harper; Katie B Biello; Matthew J Mimiaga
Journal:  AIDS Care       Date:  2019-10-13

3.  Assessing priorities for combination HIV prevention research for men who have sex with men (MSM) in Africa.

Authors:  Stefan Baral; Andrew Scheibe; Patrick Sullivan; Gift Trapence; Andrew Lambert; Linda-Gail Bekker; Chris Beyrer
Journal:  AIDS Behav       Date:  2013-05

4.  Sex on demand: geosocial networking phone apps and risk of sexually transmitted infections among a cross-sectional sample of men who have sex with men in Los Angeles County.

Authors:  Matthew R Beymer; Robert E Weiss; Robert K Bolan; Ellen T Rudy; Linda B Bourque; Jeffrey P Rodriguez; Donald E Morisky
Journal:  Sex Transm Infect       Date:  2014-06-12       Impact factor: 3.519

5.  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

Authors:  K Bush; D R Kivlahan; M B McDonell; S D Fihn; K A Bradley
Journal:  Arch Intern Med       Date:  1998-09-14

6.  Knowledge and Acceptability of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Ghana.

Authors:  Adedotun Ogunbajo; Natalie M Leblanc; Sameer Kushwaha; Francis Boakye; Samuel Hanson; Martez D R Smith; LaRon E Nelson
Journal:  AIDS Care       Date:  2019-10-10

7.  Mental health and HIV risk in men who have sex with men.

Authors:  Steven A Safren; Sari L Reisner; Amy Herrick; Matthew J Mimiaga; Ronald D Stall
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

8.  The effect of psychosocial syndemic production on 4-year HIV incidence and risk behavior in a large cohort of sexually active men who have sex with men.

Authors:  Matthew J Mimiaga; Conall OʼCleirigh; Katie B Biello; Angela M Robertson; Steven A Safren; Thomas J Coates; Beryl A Koblin; Margaret A Chesney; Deborah J Donnell; Ron D Stall; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2015-03-01       Impact factor: 3.731

9.  HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.

Authors:  Deborah Donnell; Jared M Baeten; Namandjé N Bumpus; Justin Brantley; David R Bangsberg; Jessica E Haberer; Andrew Mujugira; Nelly Mugo; Patrick Ndase; Craig Hendrix; Connie Celum
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

Review 10.  Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis.

Authors:  Siyan Yi; Sovannary Tuot; Grace W Mwai; Chanrith Ngin; Kolab Chhim; Khoundyla Pal; Ewemade Igbinedion; Paula Holland; Sok Chamreun Choub; Gitau Mburu
Journal:  J Int AIDS Soc       Date:  2017-06-26       Impact factor: 5.396

View more
  6 in total

1.  Poor sleep health is associated with increased mental health problems, substance use, and HIV sexual risk behavior in a large, multistate sample of gay, bisexual and other men who have sex with men (GBMSM) in Nigeria, Africa.

Authors:  Adedotun Ogunbajo; Arjee Restar; Alberto Edeza; William Goedel; Harry Jin; Stella Iwuagwu; Rashidi Williams; Mohammed Rabiu Abubakari; Katie Biello; Matthew Mimiaga
Journal:  Sleep Health       Date:  2020-03-20

2.  Transactional Sex Is Associated with Income Level and Psychosocial Health Problems among Gay and Bisexual Men (GBM) in Nigeria, Africa.

Authors:  Adedotun Ogunbajo; Gamji M'Rabiu Abubakari; Alberto Edeza; Stella Iwuagwu; Rashidi Williams; Katie Biello; Matthew J Mimiaga
Journal:  J Sex Res       Date:  2020-12-07

3.  Validation of depressive symptoms, social support, and minority stress scales among gay, bisexual, and other men who have with men (GBMSM) in Nigeria, Africa: a mixed methods approach.

Authors:  Adedotun Ogunbajo; Stella Iwuagwu; Rashidi Williams; Katie B Biello; Christopher W Kahler; Theodorus G M Sandfort; Matthew J Mimiaga
Journal:  BMC Public Health       Date:  2020-06-29       Impact factor: 3.295

4.  Engagement in the pre-exposure prophylaxis (PrEP) cascade among a respondent-driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbabwe.

Authors:  Lauren E Parmley; Tiffany G Harris; Innocent Chingombe; Munyaradzi Mapingure; Owen Mugurungi; John H Rogers; Perpetua Gozhora; Yingfeng Wu; Chesterfield Samba; Godfrey Musuka; Avi J Hakim
Journal:  J Int AIDS Soc       Date:  2022-02       Impact factor: 5.396

Review 5.  HTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review.

Authors:  Daniel Bradshaw; Graham Philip Taylor
Journal:  Front Med (Lausanne)       Date:  2022-04-29

6.  Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin.

Authors:  Carin Ahouada; Souleymane Diabaté; Myrto Mondor; Septime Hessou; Fernand A Guédou; Luc Béhanzin; Georges Batona; Ndeye Ndiagna Gning; D Marcel Zannou; Michel Alary
Journal:  BMC Public Health       Date:  2020-08-20       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.